Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib

NCT02538627 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Colorectal Cancer
Non-small Cell Lung Cancer
Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: MM-151
DRUG: MM-121
DRUG: MM-141
DRUG: trametinib

Sponsor

Merrimack Pharmaceuticals